Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
for
Newly Diagnosed Glioblastoma,
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT05864534
Phase2, Recruiting
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
for
Glioblastoma, Glioblastoma Multiforme,
Location: Boston MA, San Francisco CA
Sponsor: Jasper Gerritsen
Sex: All
Age: 18 - 70+
Code: NCT06146738
Recruiting
OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
for
Recurrent Glioblastoma
Location: Gainesville FL
Sponsor: University of Florida
Sex: All
Age: 18 - 70+
Code: NCT06558214
Phase2, Recruiting
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
for
Neurological Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT03922555
Phase1, Recruiting
Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
for
Glioblastoma
Location: Louisville KY
Sponsor: University of Louisville
Sex: All
Age: 18+
Code: NCT05700955
Phase1, Recruiting
Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients
for
Glioblastoma Multiforme
Location: Edmonton
Sponsor: AHS Cancer Control Alberta
Sex: All
Age: 65+
Code: NCT04765514
Phase2, Recruiting
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
for
Glioblastoma
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio
Sex: All
Age: 0+
Code: NCT04863950
Phase2, Recruiting
Serial MRI Scans During Radiation Therapy
for
Glioblastoma, Esophageal Cancer, Radiotherapy,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04188535
Recruiting
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer